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Abstract  
Background: Nuclease and caspase enzymes activities which promote death signals and lead to 
apoptosis are dependent to potassium ions. 
Objective: The aim of this study was to determine the effect of 4-aminopyridine (4-AP) potassium 
channel blocker on the animal model of Parkinson's disease.   
Methods: This experimental study was performed in Qazvin University of Medical Sciences, 2013. 
Male Rats were received different doses of 4-AP twice daily from half an hour before injection of 6-
hydroxydopamine (6-OHDA) to 7 or 15 days after that. 6-OHDA was injected into medial forebrain 
bundle (MFB) in acute model groups and into striatum in chronic model groups. The severity of 
Parkinsonism was assessed by standard behavioral methods. Data were analyzed using Kruskal-
Wallis and Mann Whitney U tests. 
Findings: In acute model groups, administration of 0.5 mg/kg 4-AP (n=9) had no remarkable effect 
on behavioral symptoms, but 1 mg/kg 4-AP (n=8) significantly reduced the severity of 
apomorphine-induced rotations and improved motor learning in rotarod test. In chronic model 
groups, although 1 mg/kg 4-AP (n=7) significantly reduced the severity of rotations and improved 
motor learning, but 0.5 mg/kg 4-AP (n=8) was more effective. 
Conclusion: Pretreatment with 4-AP can reduce 6-OHDA-induced dopaminergic neuron death. 
Since the chronic model of 6-OHDA is more similar to Parkinson's disease in human, the low dose 
of 4-AP is recommended for treatment of this disease.  
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